Access the full text.
Sign up today, get DeepDyve free for 14 days.
P Athma, R Rappaport, M Swift (1996)
Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancerCancer Genet Cytogenet, 92
T Ripperger, D Gadzicki, A Meindl, B Schlegelberger (2009)
Breast cancer susceptibility: current knowledge and implications for genetic counsellingEur J Hum Genet, 17
AC Antoniou, PD Pharoah, G McMullan, NE Day, BA Ponder, D Easton (2001)
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based studyGenet Epidemiol, 21
MR Stratton, N Rahman (2008)
The emerging landscape of breast cancer susceptibilityNat Genet, 40
CI Li, JR Daling, KE Malone (2006)
Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancerCancer Epidemiol Biomarkers Prev, 15
AM Goldstein, CI Amos (1990)
Segregation analysis of breast cancer from the cancer and steroid hormone study: histologic subtypesJ Natl Cancer Inst, 82
LA Brinton, D Richesson, MF Leitzmann (2008)
Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study CohortCancer Epidemiol Biomarkers Prev, 17
J Peto, TM Mack (2000)
High constant incidence in twins and other relatives of women with breast cancerNat Genet, 26
DJ Ciske, SS Rich, RA King (1996)
Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility modelsGenet Epidemiol, 13
E Anderson, J Berg, R Black (2008)
Predicting breast cancer risk: implications of a ?weak? family historyFam Cancer, 7
HL Olsson (2009)
Lobular breast carcinoma as a possible candidate phenotype for recessively inherited breast cancerCancer Res, 69
H Jernstrom, J Frenander, M Ferno, H Olsson (1999)
Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patientsBr J Cancer, 80
DF Easton (1999)
How many more breast cancer predisposition genes are there?Breast Cancer Res, 1
JM O’Brien (2000)
Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland, by P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki. N Engl J Med 343:78?84, 2000Surv Ophthalmol, 45
CI Amos, AM Goldstein, EL Harris (1991)
Familiality of breast cancer and socioeconomic status in blacksCancer Res, 51
MD Lagios, MR Rose, FR Margolin (1980)
Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinomaAm J Clin Pathol, 73
L Tabar, PB Dean (2003)
Mammography and breast cancer: the new eraInt J Gynaecol Obstet, 82
DJ Kaufman, TH Beaty, JP Struewing (2003)
Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genesCancer Epidemiol Biomarkers Prev, 12
While a dominant inheritance of breast cancer (vertical inheritance) is well known, less is known about a possible recessive inheritance (horizontal inheritance). In a clinical series of 1676 breast cancer patient’s family history was scored as vertical (grandmother-aunt-mother-sister-daughter) or horizontal (sister-sister) and related to histopathological tumor type, presence of germline mutations, bilaterality, multifocality, screening, parity, hormone replacement therapy (HRT) use and age at diagnosis. Prognosis was estimated by also adding tumor size, lymph node status, distant metastases and hormone receptor status at diagnosis into a Cox proportional hazard model. Excluding mutations carriers, a horizontal family history (5% of all cases) was significantly associated with tubular tumor type [OR = 3.87(1.44–10.41)]. A vertical family history (23% of all cases) was significantly related to tumor multifocality [OR = 2.30(1.51–3.50)], tumor bilaterality [OR = 2.08(1.44–3.00)] and screening detection [OR = 1.50(1.10–2.05)]. No significant difference in survival could be seen between patients with none, horizontal or vertical family history. However, germline mutation carriers (BRCA1/2, TP53 or CDKN2A, present in 0.95% of the cases) had a significantly worse survival. Screening detected cases, HRT ever users and patients with estrogen receptor positive tumors had a significantly better survival adjusting for age at diagnosis, tumor size, lymph node status and presence of distant metastases at diagnosis. Factors associated with a horizontal family history were found, defining a possible phenotype for a recessive inheritance: tubular breast cancer.
Familial Cancer – Springer Journals
Published: Jun 13, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.